Next, we plotted the ROC with AUC greater than 0.8 for CLDN12 in pan-cancer (Fig. 2B) and found that it was largest in glioblastoma multiforme (GBM) at 0.9621, followed by LUAD at 0.9311. Here, CLDN12 is linked to cancer.